ADA 2023
ADA 2023
American Diabetes Association's 83rd Scientific Sessions
Advertisement
Patrick DalyADA 2023 | June 30, 2023
A novel treatment, VX-880, restored insulin secretion and reduced exogenous insulin use in patients with type 1 diabetes.
Read More
Patrick DalyADA 2023 | June 29, 2023
Blood glucose in children was able to predict future diabetes-related complications, including kidney and eye disease.
Rob DillardADA 2023 | June 28, 2023
DPP-4 inhibitors, used to control blood sugar levels in adults with type 2 diabetes, may reduce the risk of melanoma.
Rob DillardADA 2023 | June 27, 2023
A multidisciplinary approach significantly increases the prescription of evidence-based therapies for T2D and heart disease.
Rob DillardADA 2023 | August 22, 2023
A study sought to differentiate between diabetes due to pancreatic cancer and type 2 diabetes.
Rob DillardADA 2023 | July 17, 2023
A cholesterol lowering nonstatin therapy can potentially mitigate heart disease death. Results from the CLEAR Outcomes trial.
Rob DillardADA 2023 | June 25, 2023
Diabetes appears to play a critical role in the progression from preclinical heart failure (HF) to overt HF.
Rob DillardADA 2023 | June 25, 2023
Using tirzepatide may be an effective weight-loss option for individuals with type 2 diabetes who have obesity.
Advertisement
Advertisement
Advertisement
Latest News

May 24, 2024